Norges Bank’s PharMerica Corporation PMC Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2017
Q4 | – | Sell |
-246,745
| Closed | -$7.23M | – | 2155 |
|
|
2017
Q3 | $7.23M | Buy |
246,745
+78,588
| +47% | +$2.2M | ﹤0.01% | 1802 |
|
|
2017
Q2 | $4.41M | Hold |
168,157
| – | – | ﹤0.01% | 1908 |
|
|
2017
Q1 | $3.94M | Buy |
168,157
+14,510
| +9% | +$358K | ﹤0.01% | 1923 |
|
|
2016
Q4 | $3.86M | Buy |
153,647
+119,305
| +347% | +$3.01M | ﹤0.01% | 1902 |
|
|
2016
Q3 | $921K | Sell |
34,342
-262,209
| -88% | -$6.72M | ﹤0.01% | 2053 |
|
|
2016
Q2 | $7.31M | Sell |
296,551
-97,880
| -25% | -$2.43M | ﹤0.01% | 1759 |
|
|
2016
Q1 | $8.72M | Hold |
394,431
| – | – | ﹤0.01% | 1639 |
|
|
2015
Q4 | $13.8M | Hold |
394,431
| – | – | 0.01% | 1390 |
|
|
2015
Q3 | $11.2M | Sell |
394,431
-2,243
| -0.6% | -$75.4K | 0.01% | 1475 |
|
|
2015
Q2 | $13.2M | Buy |
396,674
+7,140
| +2% | +$219K | 0.01% | 1450 |
|
|
2015
Q1 | $11M | Sell |
389,534
-4,987
| -1% | -$124K | 0.01% | 1592 |
|
|
2014
Q4 | $8.17M | Buy |
394,521
+83,096
| +27% | +$1.97M | ﹤0.01% | 1734 |
|
|
2014
Q3 | $7.61M | Sell |
311,425
-241,425
| -44% | -$6.4M | ﹤0.01% | 1729 |
|
|
2014
Q2 | $15.8M | Buy |
552,850
+276,425
| +100% | +$7.69M | ﹤0.01% | 1731 |
|
|
2014
Q1 | $7.73M | Hold |
276,425
| – | – | ﹤0.01% | 1712 |
|
|
2013
Q4 | $5.94M | Hold |
276,425
| – | – | ﹤0.01% | 1834 |
|
|
2013
Q3 | $3.67M | Hold |
276,425
| – | – | ﹤0.01% | 1981 |
|
|
2013
Q2 | $3.83M | Buy |
+276,425
| New | +$3.92M | ﹤0.01% | 1955 |
|
Norges Bank's PMC Position: Q4 2017 in Review
Norges Bank sold out of PharMerica Corporation (PMC) in Q4 2017, closing a stake of 246,745 shares — an estimated $7.23M sold.
Norges Bank first reported a position in PMC in Q2 2013 and held it in 18 quarters. The position peaked at $15.8M in Q2 2014. 0 funds tracked by Wall St. Rank hold PMC as of Q4 2017.
- Norges Bank reported no remaining PharMerica Corporation position as of Q4 2017 after selling out during the quarter.
- Norges Bank sold 246,745 PharMerica Corporation shares in Q4 2017, an estimated $7.23M.
- Norges Bank first reported a position in PharMerica Corporation in Q2 2013 and held it in 18 quarters.
- Norges Bank's PharMerica Corporation position peaked at $15.8M in Q2 2014.
- 0 funds tracked by Wall St. Rank held PharMerica Corporation as of Q4 2017.
Based on Norges Bank's 13F filing for Q4 2017, filed 9 Feb 2018.